Moreover, elevated mRNA expression levels of PLCB1, PLCB2, and PLCB3 were linked to poor OS of every NSCLC patient and were significantly associated with poor prognosis of AC. The gene discussed is PLCB2; the disease is non-small cell lung carcinoma.